英文名称 | 中文名称 | CAS | MF |
(anthracen-1-yl)methanamine
|
|
|
C15H13N
|
Anti-human Cystatin A (WR 23 /2 /3 /3)
|
抗人胱抑素A
|
|
|
Mordant Red 5
|
媒介红 5
|
3564-26-9
|
C12H11N2NaO6S
|
9-ANTHRACENECARBOXYLIC ACID, (9-ANTHROIC ACID)
|
|
|
C30H20O4
|
3-ANTHRANILOYL-DL-ALANINE SULFATE
|
|
|
C10H14N2O7S
|
3-(9-ANTHRYL)-1-(2-NAPHTHYL)PROP-2-EN-1-ONE, TECH
|
|
|
C27H18O
|
3-(9-ANTHRYL)-1-(3-METHYLPHENYL)PROP-2-EN-1-ONE, TECH
|
|
|
C24H18O
|
anthranilic acid dihydrochloride
|
|
7459-95-2
|
C7H9Cl2NO2
|
ANTI-HUMAN IGM (MU-CHAIN SPECIFIC)-ALKALINE PHOSPHATASE
|
|
|
|
2-(9-ANTHROYLOXY)STEARIC ACID
|
|
|
C33H44O4
|
ANTI-HUMAN IL-5, BIOTIN
|
|
|
|
1,5-Anthraquinone Disulfonic acid Sodium salt
|
|
|
C14H6Na2O8S2
|
ANTI-HSORC4
|
|
|
|
ANTI-HUMANTHYMOCYTEGLOSILIN
|
|
|
|
Anthracene, reaction products with sulfur chloride
|
还原橄榄绿 3G
|
1328-13-8
|
|
ANTI-HUMAN RB (AA 514-610)
|
|
|
|
ANTHRONE - ACS (98% CONTENT)
|
|
|
|
(+-)-12-(9-ANTHROYLOXY)STEARIC ACID
|
|
30536-60-8
|
C33H44O4
|
(anthracen-2-yl)methanamine
|
|
|
C15H13N
|
1-(anthracen-9-yl)ethanethione
|
|
|
C16H12S
|
Anthranilic acid, N-(6-bromo--alpha-,-alpha-,-alpha--trifluoro-m-tolyl)- (8CI)
|
|
802038-58-0
|
C14H9BrF3NO2
|
Anthranilic acid, 5-(dimethylsulfamoyl)-N-(-alpha-,-alpha-,-alpha--trifluoro-m-tolyl)- (7CI,8CI)
|
|
2024-65-9
|
C16H15F3N2O4S
|
Anthranilic acid, 3,4,5,6-tetrachloro-N-(2,3,4,5-tetrachlorophenyl)- (7CI,8CI)
|
|
4901-56-8
|
C13H3Cl8NO2
|
ANTI-HIF-1ALPHA
|
|
|
|
Anthraquinone, 1,3-dihydroxy-2-methoxy-
|
1,3-二羟基-2-甲氧基蒽醌
|
10383-63-8
|
C15H10O5
|
ANTI-HUMAN IGG (GAMMA-CHAIN SPECIFIC)-FITC
|
|
|
|
ANTHRAQUINONE MONOHYDRAZONE
|
|
3166-13-0
|
C14H10N2O
|
ANTI-HUMAN CD150, PE
|
|
|
|
ANTI-HUMAN CD42B, R-PE CONJUGATE
|
|
|
|
ANTI-HUMAN MUC2
|
|
|
|
1-(9-ANTHRYL)-2,2,2-TRIFLUOROETHAN-1-ONE
|
|
|
C16H9F3O
|
9-anthracenecarbaldehyde (5-isopropyl-4-oxo-1,3-thiazolidin-2-ylidene)hydrazone
|
|
380641-57-6
|
C21H19N3OS
|
9-anthracenecarbaldehyde [4-{4-nitroanilino}-6-(2-toluidino)-1,3,5-triazin-2-yl]hydrazone
|
|
|
C31H24N8O2
|
ANTI-HUMAN HLA CLASS II, (DR+DP+DQ), BIOTIN CONJUGATE
|
|
|
|
ANTI-HIV-I, GP41, FLUORESCEIN
|
|
|
|
5-(9-anthrylmethylene)-1-butyl-3-(2-phenylethyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
|
|
353285-87-7
|
C31H28N2O3
|
4-(9-anthrylmethylene)-2-(4-bromophenyl)-5-methyl-2,4-dihydro-3H-pyrazol-3-one
|
|
352522-88-4
|
C25H17BrN2O
|
6-(9-anthryl)-3-(benzylsulfanyl)-6,7-dihydro[1,2,4]triazino[5,6-d][3,1]benzoxazepine
|
|
353517-69-8
|
C31H22N4OS
|
9-anthracenecarbaldehyde [4-(3,5-dimethyl-1H-pyrazol-1-yl)-6-(4-toluidino)-1,3,5-triazin-2-yl]hydrazone
|
|
957491-69-9
|
C30H26N8
|
4-(9-anthrylmethylene)-2-(methylsulfanyl)-1,3-thiazol-5(4H)-one
|
|
|
C19H13NOS2
|
3-(9-anthryl)-1-{4-[(trimethylsilyl)methyl]phenyl}-2-propen-1-one
|
|
|
C27H26OSi
|
5-(9-anthrylmethylene)-3-(4-bromobenzyl)-2,4-imidazolidinedione
|
|
445429-09-4
|
C25H17BrN2O2
|
2-(9-anthryl)-4,5-di[1,1'-biphenyl]-4-yl-1H-imidazole
|
|
312320-15-3
|
C41H28N2
|
9-anthracenecarbaldehyde (5-ethyl-4-oxo-1,3-thiazolidin-2-ylidene)hydrazone
|
|
380641-73-6
|
C20H17N3OS
|
4-[(9-anthrylmethylene)amino]benzenesulfonamide
|
|
|
C21H16N2O2S
|
4-(9-anthrylmethylene)-1-(4-methylphenyl)-3,5-pyrazolidinedione
|
|
491864-29-0
|
C25H18N2O2
|
5-(9-anthrylmethylene)-3-(3-fluorophenyl)-2-thioxo-1,3-thiazolidin-4-one
|
|
|
C24H14FNOS2
|
9-anthracenecarbaldehyde (6-methyl-5H-[1,2,4]triazino[5,6-b]indol-3-yl)hydrazone
|
|
327031-23-2
|
C25H18N6
|
6-(9-anthrylmethylene)-5-imino-2-(1-phenylpropyl)-5,6-dihydro-7H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one
|
|
|
C29H22N4OS
|
2-[2-(9-anthrylmethylene)hydrazino]-N-methyl-2-oxoacetamide
|
|
|
C18H15N3O2
|
1-(9-anthryl)-3-(2-chloro-7-ethoxy-3-quinolinyl)-2-propen-1-one
|
|
|
C28H20ClNO2
|
4-(9-anthrylmethylene)-2-(4-methylphenyl)-1,3-oxazol-5(4H)-one
|
|
301655-92-5
|
C25H17NO2
|
ANTI-HIV-1, GP17
|
|
|
|
ANTI-HUMAN IGG AND M AND A (HEAVY) HRPO
|
|
|
|
ANTI-HRAD51D
|
|
|
|
anthrahydroquinone diacetate
|
9,10-蒽二酚二乙酸酯
|
|
C14H8(OOCCH3)2
|
Anthramycin
|
安曲霉素
|
4803-27-4
|
C16H17N3O4
|
ANTI-HUMAN BETA-AMYLOID PEPTIDE-BIOTIN
|
|
|
|
ANTHRAQUINONE-2-SULFONIC ACID IRON(III) SALT HYDRATE
|
|
|
C42H23FeO16S3
|
ANTI-HUC
|
|
|
|
ANTI-HUMAN FASCIN
|
|
|
|
ANTI-HLA-DR, DP, DQ FITC CONJUGATE
|
|
|
|
ANTI-HES-5
|
ANTI-HES-5
|
|
|
9,10-ANTHRACENEDIYL-BIS(METHYLENE)DIMALONIC ACID
|
|
|
C22H18O8
|
ANTI-HUMAN PROTEIN S HRP CONJUGATED
|
|
|
|
ANTI-HUMAN IGA, SECRETORY FITC CONJUGATED
|
|
|
|
Anthraergosta-5,7,9,22-tetren-3-ol hexahydrobenzoate
|
|
105819-17-8
|
C35H52O2
|
ANTI-5-HT1A RECEPTOR
|
|
|
|
ANTHRAQUINONE-1-AMINO-5-SULPHONIC ACID AMMONIUM SALT
|
蒽醌-1-氨基-5-磺酸铵
|
|
C14H12N2O5S
|
ANTHRAQUINONE-1,8- DISULPHONIC ACID POTASSIUM
|
|
|
C14H6K2O8S2
|
ANTI-HUMAN CD206, APC
|
|
|
|
ANTHRACENE SOLUTION 100UG/ML IN METHANOL 5ML
|
|
|
C14H10
|
3-(9-ANTHRYL)-1-(3-METHOXYPHENYL)PROP-2-EN-1-ONE, TECH
|
|
|
C24H18O2
|
3-(9-ANTHRYL)-1-(2-PHENANTHRYL)PROP-2-EN-1-ONE, TECH
|
|
|
C31H20O
|
ANTI-HUMAN IGG (GAMMA-CHAIN SPECIFIC)-PEROXIDASE
|
|
|
|
ANTI-HUMAN CD71, PE-CY5
|
|
|
|
ANTI-HUMAN NEURITIN EXTRACELLULAR DOMAIN
|
|
|
|
ANTI-HUMAN DR5 EXTRACELLULAR DOMAIN
|
|
|
|
ANTI-HORSE IGM (MU CHAIN SPECIFIC), ALKALINE PHOSPHATASE
|
|
|
|
ANTI-HLA, CLASS II ANTIGEN-DP (MONOMORPHIC) FITC CONJUGATED
|
|
|
|
ANTI-HUMAN CD140B EXTRACELLULAR DOMAIN, BIOTIN
|
|
|
|
ANTI-HUMAN NF-ATC1
|
|
|
|
ANTI-HUMAN CD68 FITC
|
|
|
|
ANTI-HUMAN FACTOR V
|
|
|
|
ANTI-HUMAN PAI-3
|
|
|
|
ANTI-HUMAN FIBROBLAST GROWTH FACTOR-17
|
|
|
|
ANTI-HUMAN GAS 6 AA 118 - 678
|
|
|
|
ANTI-HUMAN CD209L, FLUORESCEIN
|
|
|
|
ANTI-HOX A2
|
|
|
|
9,10-Anthraquinone-1,8-Disulphonic Acid Postassium Salt
|
|
|
C14H6K2O8S2
|
ANTI-HUMAN CCL19, BIOTIN
|
|
|
|
2-Bromo-9,10-bis(2-naphthalenyl)anthracene
|
2-溴-9,10-双(2-萘基)蒽
|
474688-76-1
|
C34H21Br
|
ANTI-HUMAN IGG (FAB SPECIFIC) DEVELOPED IN GOAT AFF
|
|
|
|
3-(9-anthrylmethylene)-5-phenyl-2(3H)-furanone
|
|
311793-12-1
|
C25H16O2
|
6-(9-anthrylmethylene)-5-imino-3-phenyl-5,6-dihydro-7H-[1,3]thiazolo[3,2-a]pyrimidin-7-one
|
|
381174-96-5
|
C27H17N3OS
|
Anthraquinone-α-arsonic acid
|
蒽醌-1-胂酸
|
|
C14H9AsO5
|
ANTI-HUMAN 2B4, FITC
|
|
|
|
ANTI-HUMAN FLI-1
|
ANTI-HUMAN FLI-1
|
|
|
ANTI-HUMAN B-CELLS LO-PAN B-A, BA
|
|
|
|
ANTI-HUMAN THYMUS MEDULLA
|
|
|
|